EXACT Therapeutics AS

OB:EXTX Stok Raporu

Piyasa değeri: NOK 192.5m

EXACT Therapeutics Yönetim

Yönetim kriter kontrolleri 3/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Per Walday

İcra Kurulu Başkanı

NOK 2.8m

Toplam tazminat

CEO maaş yüzdesi80.2%
CEO görev süresi2.4yrs
CEO sahipliğin/a
Yönetim ortalama görev süresi2.3yrs
Yönetim Kurulu ortalama görev süresi5.1yrs

Son yönetim güncellemeleri

Recent updates

Here's Why We're Watching EXACT Therapeutics' (OB:EXTX) Cash Burn Situation

Aug 09
Here's Why We're Watching EXACT Therapeutics' (OB:EXTX) Cash Burn Situation

Is EXACT Therapeutics (OB:EXTX) In A Good Position To Invest In Growth?

Apr 20
Is EXACT Therapeutics (OB:EXTX) In A Good Position To Invest In Growth?

We Think EXACT Therapeutics (OB:EXTX) Can Afford To Drive Business Growth

Sep 07
We Think EXACT Therapeutics (OB:EXTX) Can Afford To Drive Business Growth

We're Hopeful That EXACT Therapeutics (OB:EXTX) Will Use Its Cash Wisely

May 06
We're Hopeful That EXACT Therapeutics (OB:EXTX) Will Use Its Cash Wisely

Here's Why We're Watching EXACT Therapeutics' (OB:EXTX) Cash Burn Situation

Dec 30
Here's Why We're Watching EXACT Therapeutics' (OB:EXTX) Cash Burn Situation

Companies Like EXACT Therapeutics (OB:EXTX) Are In A Position To Invest In Growth

Sep 15
Companies Like EXACT Therapeutics (OB:EXTX) Are In A Position To Invest In Growth

EXACT Therapeutics (OB:EXTX) Is In A Good Position To Deliver On Growth Plans

Jan 31
EXACT Therapeutics (OB:EXTX) Is In A Good Position To Deliver On Growth Plans

We Think EXACT Therapeutics (OB:EXTX) Can Afford To Drive Business Growth

Aug 21
We Think EXACT Therapeutics (OB:EXTX) Can Afford To Drive Business Growth

We're Not Very Worried About EXACT Therapeutics' (OB:EXTX) Cash Burn Rate

May 21
We're Not Very Worried About EXACT Therapeutics' (OB:EXTX) Cash Burn Rate

CEO Tazminat Analizi

Per Walday'un ücretlendirmesi EXACT Therapeutics'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 30 2024n/an/a

-NOK 55m

Mar 31 2024n/an/a

-NOK 52m

Dec 31 2023NOK 3mNOK 2m

-NOK 48m

Sep 30 2023n/an/a

-NOK 42m

Jun 30 2023n/an/a

-NOK 36m

Mar 31 2023n/an/a

-NOK 38m

Dec 31 2022NOK 2mNOK 1m

-NOK 40m

Tazminat ve Piyasa: Per 'ın toplam tazminatı ($USD 256.27K ) Norwegian pazarındaki benzer büyüklükteki şirketler için ortalamadır ($USD 299.21K ).

Tazminat ve Kazançlar: Per şirketinin tazminatı, şirket kârsız olduğu sürece artırıldı.

CEO

Per Walday (64 yo)

2.4yrs

Görev süresi

NOK 2,833,302

Tazminat

Dr. Per Walday, Ph D., has been the Chief Executive Officer at PCI Biotech AS since 2008. He serves as Chief Executive Officer at EXACT Therapeutics AS since June 5, 2022.Dr. Walday had been the Chief Exe...

Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Per Walday
Chief Executive Officer2.4yrsNOK 2.83mVeri yok
Masha Paule Nathalie Stromme
Vice-Chair of the Board9.8yrsNOK 445.00kVeri yok
Svein Kvåle
Co Founder & COOno dataNOK 1.65m9.43%
NOK 18.1m
John Edminson
Chief Financial Officer2.1yrsNOK 2.02mVeri yok
Amir Snapir
Chief Medical Officer2.2yrsNOK 2.66mVeri yok
Caspar Foghsgaard
Chief Business Officerless than a yearNOK 250.00kVeri yok
Per Sontum
Founderno dataNOK 2.49m5.99%
NOK 11.5m
Ragnar Bendicksen
Vice President of Technology2.6yrsVeri yokVeri yok

2.3yrs

Ortalama Görev Süresi

Deneyimli Yönetim: EXTX 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 2.3 yıldır).

Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Masha Paule Nathalie Stromme
Vice-Chair of the Board9.8yrsNOK 445.00kVeri yok
William Castell
Director6.8yrsNOK 275.00k1.05%
NOK 2.0m
Anders Wold
Chair of the Board2.9yrsNOK 510.00kVeri yok
Ann-Tove Kongsnes
Director3.4yrsNOK 260.00kVeri yok

5.1yrs

Ortalama Görev Süresi

Deneyimli Yönetim Kurulu: EXTX 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 5.1 yıldır).